Genetic polymorphisms affecting immune synapse integrity, MHC expression, and cytoskeletal regulation (e.g., PTPN22, LILRB1) may modulate trogocytosis efficiency and influence SLE heterogeneity (Reed et al., 2021). The gene discussed is LILRB1; the disease is systemic lupus erythematosus.